An FDA-funded study using real-world evidence to replicate the results of a randomized, controlled clinical trial showed that the approach might be useful, but some experts said trials based on observational data cannot safely replace prospective clinical trials in regulatory or clinical decision-making. Others also said RWE studies are effective for judging drug safety.
Experts debate the benefits, risks of trials based on RWE
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.